263700 — Carelabs Co Income Statement

0.000.00%

Last trade - 00:00

TechnologyHighly SpeculativeMicro CapNeutral

Market Cap
KR₩46bn
Enterprise Value
KR₩19bn
Revenue
KR₩82bn

Annual income statement for Carelabs Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	93,934	87,607	81,827	83,187	81,694
Cost of Revenue
Gross Profit	89,250	84,637	79,736	82,141	80,119
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	92,787	105,004	97,361	93,922	84,571
Operating Profit	1,147	-17,397	-15,534	-10,735	-2,877
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	3,936	-26,789	-21,648	-19,139	23,429
Provision for Income Taxes
Net Income After Taxes	1,242	-26,388	-23,867	-19,670	19,512
Minority Interest
Net Income Before Extraordinary Items
Net Income	1,253	-26,124	-24,470	-20,280	19,179
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	1,253	-26,124	-24,470	-20,280	19,179
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	152	-994	-1,144	-685	130
Dividends per Share